Global Senior Director, Medical Affairs - Atherosclerosis

Job Description

The Global Senior Director, Medical Affairs (GDMA) is responsible for driving execution of value and implementation plans for atherosclerosis programs in key countries and regions. They are impactful members of Product Development Team sub-teams and Global Human Health commercialization teams. They collaborate with global Commercial, Outcomes Research (OR), Policy and Market Access to address opportunities in key countries. They contribute to the development of a single global scientific communications platform. They consolidate actionable medical insights from countries and regions. They engage with a network of international scientific leaders and other key stakeholders (therapeutic guideline committees, payers, public groups, government officials, medical societies) about emerging science. They organize global expert input events to answer questions how to implement new medicines: advisory boards and expert input forums. They organize global symposia and educational meetings. They support key countries with the development of local data generation study concepts and protocols. They review investigator-initiated study proposals from key countries prior to headquarters submission (ex-USA). This is a headquarters-based role.

Primary Responsibilities:

• Co-chairs the Value and Implementation team with an Outcomes Research colleague for atherosclerosis assets

• Chairs the cross functional medical team for atherosclerosis assets

• Drives execution of the annual V&I plan with medical affairs colleagues from key countries and regions.

• Is impactful member of Product Development Team sub-teams (Clinical, Value Evidence, Commercial, Publications and Label) and Global Human Health commercialization teams.

• Contributes to the development of a single global scientific communications platform.

• Consolidates actionable medical insights from countries and regions.

• Engages with a network of international scientific leaders and other key stakeholders (therapeutic guideline committees, payers, public groups, government officials, medical societies) about our organization's emerging science.

• Organizes global expert input events to answer our organization's questions how to develop and implement new medicines/vaccines: advisory boards and expert input forums.

• Aligns plans and activities with Global Human Health (commercial) executive directors.

• Organizes global symposia and educational meetings.

• Supports key countries with the development of local data generation study concepts and protocols.

• Reviews investigator-initiated study proposals from key countries prior to headquarters submission (ex-USA).

• Manages programs (patient support, educational or risk management) to support appropriate and safe utilization of our organization's medicines/vaccines.

• Desire to contribute to an environment of belonging, engagement, equity, and empowerment by: 

• Working to transform the environment, culture, and business landscape 

• Leveraging diversity and inclusion to increase competitive advantage, per global diversity and inclusion strategy 

• Ensuring accountability to drive an inclusive culture 

• Strengthening the foundational elements of diversity 

• Consistent adherence to field and corporate policies and Global Medical Scientific Affairs (GMSA) strategy, including field standard operating procedures (SOPs), Good Clinical Practice (GCP) guidelines, and administrative/operational responsibilities 
   

​Education Minimum Requirements:

• MD, PhD or PharmD and recognized medical expertise/specialization in cardiology, nephrology, pulmonology or internal medicine.

Required Experience and Skills:

• Strong prioritization and decision-making skills.

• In a matrix environment, able to effectively collaborate with partners across divisions.

• Excellent interpersonal, analytical, communication (written as well as oral), in addition to results-oriented project management skills.

Preferred Experience and Skills:

• 5 years' experience in Medical Affairs or Clinical Development.

• Scientific leadership and other key stakeholders (payers, public groups, government officials, medical professional organizations) in the assigned therapeutic area.

NOTICE FOR INTERNAL APPLICANTS

In accordance with